PROM1 and glioblastoma: In vitro, GBM-derived neurosphere cultures with GSI-18, a Notch inhibitor, showed decreased neurosphere formation and clonogenicity [110,111], reduced expression of CD133, BMI1, OLIG2, and NESTIN [110], and increased sensitivity to radiotherapy [112].